{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:20Z","timestamp":1791357440598,"version":"4.3.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Visual hallucinations are commonly seen in various neurological and psychiatric disorders including schizophrenia. Current models of visual processing and studies in diseases including Parkinsons Disease and Lewy Body Dementia propose that Acetylcholine (Ach) plays a pivotal role in our ability to accurately interpret visual stimuli. Depletion of Ach is thought to be associated with visual hallucination generation. AchEI's have been used in the targeted treatment of visual hallucinations in dementia and Parkinson's Disease patients. In Schizophrenia, it is thought that a similar Ach depletion leads to visual hallucinations and may provide a target for drug treatment<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case Presentation<\/jats:title>\n            <jats:p>We present a case of a patient with Schizophrenia presenting with treatment resistant and significantly distressing visual hallucinations. After optimising treatment for schizophrenia we used Rivastigmine, an AchEI, as an adjunct to treat her symptoms successfully.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This case is the first to illustrate this novel use of an AchEI in the targeted treatment of visual hallucinations in a patient with Schizophrenia. Targeted therapy of this kind can be considered in challenging cases although more evidence is required in this field.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-244x-10-68","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T18:14:10Z","timestamp":1283883250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report"],"prefix":"10.1186","volume":"10","author":[{"given":"Sachin S","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizah","family":"Attard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhi","family":"Shergill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"698_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.psych.55.090902.142005","volume":"55","author":"D Kersten","year":"2004","unstructured":"Kersten D, Mamassian P, Yuille A: Object perception as bayesian inference. Annu Rev Psychology. 2004, 55: 271-304. 10.1146\/annurev.psych.55.090902.142005.","journal-title":"Annu Rev Psychology"},{"key":"698_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1098\/rstb.2005.1622","volume":"360","author":"K Friston","year":"2005","unstructured":"Friston K: A theory of cortical responses. Phil Trans R Soc B. 2005, 360: 815-836. 10.1098\/rstb.2005.1622.","journal-title":"Phil Trans R Soc B"},{"key":"698_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0893-6080(02)00058-8","volume":"15","author":"D Yu","year":"2002","unstructured":"Yu D, Dayan P: Acetylcholine in cortical inference. Neural Networks. 2002, 15: 719-730. 10.1016\/S0893-6080(02)00058-8.","journal-title":"Neural Networks"},{"issue":"6","key":"698_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000101512","volume":"23","author":"K Edwards","year":"2007","unstructured":"Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, Pasquier F, Johnson S: Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24 week open-label study. Dementia and Geriatric Cognitive Disorders. 2007, 23 (6): 401-5. 10.1159\/000101512.","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"1","key":"698_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s100720200022","volume":"23","author":"G Fabbrini","year":"2004","unstructured":"Fabbrini G, Barbanti P, Aurilia C, Pauletti C, Lenzi GL, Meco G: Donepezil in the treatment of hallucinations and delusions in Parkinson's disease. Neurological Sciences. 2004, 23 (1): 41-43. 10.1007\/s100720200022.","journal-title":"Neurological Sciences"},{"key":"698_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/ajp.157.1.4","volume":"157","author":"JL Cummings","year":"2000","unstructured":"Cummings JL: Cholinesterase Inhibitors: A new Class of Psychotropic Compounds. Am J Psychiatry. 2000, 157: 1-4-15","journal-title":"Am J Psychiatry"},{"issue":"6","key":"698_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00023210-200013060-00001","volume":"13","author":"JL Cummings","year":"2000","unstructured":"Cummings JL, Askin-Edgar S: Evidence for Psychotropic Effects of Acetylcholinesterase Inhibitors. CNS Drugs. 2000, 13 (6): 385-395. 10.2165\/00023210-200013060-00001.","journal-title":"CNS Drugs"},{"issue":"5","key":"698_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1185\/030079902125000813","volume":"18","author":"R Bullock","year":"2002","unstructured":"Bullock R, Cameron A: Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. Current Medical Research and Opinion. 2002, 18 (5): 258-64. 10.1185\/030079902125000813.","journal-title":"Current Medical Research and Opinion"},{"key":"698_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1017\/S0033291799008661","volume":"29","author":"G Haddock","year":"1999","unstructured":"Haddock G, McGarron J, Tarrier N, Faragher EB: Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999, 29: 879-889. 10.1017\/S0033291799008661.","journal-title":"Psychol Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-10-68.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-10-68\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-10-68","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-10-68.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T03:48:01Z","timestamp":1630468081000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-10-68"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-10-68","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]},"assertion":[{"value":"30 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"68"}}